Alere Profile

3.01
0.00  0.00%
44%
100%

Exercise or conversion by Khederian Robert P of 25000 shares of Alere subject to Rule 16b-3

Alere insider trading alert for exercise of common stock by Khederian Robert P, the corporate stakeholder, on October 15, 2018. This event was filed by Alere Inc with SEC on 2009-03-02. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

Alere Summary

Alere (ALR) is traded on New York Stock Exchange in USA. It is located in 51 Sawyer Road Suite 200, Waltham, MA 02453, United States and employs 9,200 people. The company currently falls under 'Mid-Cap' category with total capitalization of 4.47 B. Alere runs under Healthcare sector within Healthcare Services industry. This company has 87.58 M outstanding shares of which 3.37 M shares are presently shorted by investors with about 1.85 days to cover shorted positions. MORGAN STANLEY has about 491.85 M in cash with 93.75 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.62 which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Alere Probability Of Bankruptcy

Ownership Allocation (%)

Alere Target Price Odds Analysis

Odds Below 3.01HorizonTargetOdds Above 3.01
29.96%30 days 3.01 69.89%
Based on normal probability distribution, the odds of Alere to move above current price in 30 days from now is about 69.89% (This Alere probability density function shows the probability of Alere Stock to fall within a particular range of prices over 30 days) .

Alere Top Holders

Alere Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Vanguard Group IncCommon Shares7.1 M362.5 M
Fmr LlcCommon Shares4.3 M217.5 M
Ubs Oconnor LlcPreferred Shares367.2 K146.6 M
View Alere Diagnostics

Alere Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Alere Key Fundamentals

Alere Against Markets

Alere Current Ratings

Alere 30 Days Performance Scores

Risk Adjusted
Performance Score (0 to 100)
7 
Chance of
Financial Distress (0 to 100%)
43 
Equity ratings for Alere are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Alere Inc. offer professional diagnostic solutions and services for infectious and cardiometabolic disease, and toxicology in the United States, Europe, and internationally. more
NameAlere
CEO and President and DirectorNamal NawanaView All
Thematic Classification
Currently Active Investing Idea
Health Management
  Health Management
View All
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Bond Rating
InstrumentUSA Stock View All
RegionNorth America
Business Address51 Sawyer Road Suite 200, Waltham, MA 02453, United States
ExchangeNew York Stock Exchange
CIK Number0001145460
SectorHealthcare
IndustryHealthcare Services
BenchmarkDOW
Websitewww.alere.com
Phone781 647 3939

Alere Directors

Alere Corporate Directors

John Quelch Independent Director
John Martin Non-Executive Independent Director
Neville Miles Independent Non-Executive Director
Check also Trending Equities. Please also try Piotroski F Score module to get piotroski f score based on binary analysis strategy of nine different fundamentals.
Search macroaxis.com